Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This latest feature of MassDevice.com’s coverage highlights our three biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else today, make sure you’re still in the know with MassDevice +3.
Medical device maker DJO Global, Inc. announced that its executive vice president of U.S. commercial operations, Andrew Holman, will leave the company "to pursue other opportunities."
Newly minted DJO president & CEO Mike Mogul, former head of Stryker Corp.’s (NYSE:SYK) $4-billion-plus orthopedics division, will take over for Holman.
Sweden-based Getinge Group and its subsidiary Maquet Cardiovascular announced a definitive agreement to acquire soft tissue reinforcement technology developer Atrium Medical for $680 million.
The FDA warned U.S. eye doctors to steer clear of false promises in Lasik ads. The federal watchdog agency told docs that omitting risks and exaggerating benefits of Lasik vision-correction surgery could lead to federal enforcement.